RE
PHGE icon

RBC Europe’s BiomX PHGE Stock Holding History

RBC Europe’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9
Closed -$5.51K – 997
2021
Q3 		$5.51K Hold
9
– – ﹤0.01% 1028
2021
Q2 		$9.83K Buy
+9
New +$10.5K ﹤0.01% 958

Other funds holding PHGE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RBC Europe's PHGE Position: Q4 2021 in Review

RBC Europe sold out of BiomX (PHGE) in Q4 2021, closing a stake of 9 shares — an estimated $5.51K sold.

RBC Europe first reported a position in PHGE in Q2 2021 and held it in 2 quarters. The position peaked at $9.83K in Q2 2021. 13 funds tracked by Wall St. Rank hold PHGE as of Q4 2021.

  • RBC Europe reported no remaining BiomX position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 9 BiomX shares in Q4 2021, an estimated $5.51K.
  • RBC Europe first reported a position in BiomX in Q2 2021 and held it in 2 quarters.
  • RBC Europe's BiomX position peaked at $9.83K in Q2 2021.
  • 13 funds tracked by Wall St. Rank held BiomX as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.